5
3
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T78069 |
RPR132595A hydrochloride
NPC hydrochloride |
Drug Metabolite | Metabolism |
RPR132595A (NPC) hydrochloride,CPT-11的活性代谢产物,由细胞色素P-450 3A4 (CYP3A4) 催化产生,经尿液排出体外。 | |||
T38474 |
CL2-MMT-SN38
CL2-MMT-SN38 |
||
CL2-MMT-SN38 is a derivative of SN-38, which is a potent anticancer agent and the active metabolite of Irinotecan (CPT-11), a Topoisomerase I inhibitor. | |||
T19553 |
RPR132595A
NPC |
Others | Others |
RPR132595A is an active CPT-11 metabolite, it is generated by cytochrome P-450 3A4 (CYP3A4). | |||
T70380 |
ZBH-1205
|
||
ZBH-1205 is a novel camptothecin derivative, revealing potent antitumor activities mainly through cell apoptosis pathway, being more effective than cpt-11 and sn38 at inhibiting topoismerase-1 | |||
T78711 |
A011
|
ATM/ATR | DNA Damage/DNA Repair; PI3K/Akt/mTOR signaling |
A011,作为一种选择性的ataxia-telangiectasia mutated (ATM)抑制剂,其IC50为1.0 nM,能够在与CPT-11联合应用时,诱导Apoptosis及G2/M期细胞周期阻滞,显示出显著的抗肿瘤活性。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T6228 |
Irinotecan
CPT-11,Topotecin,伊立替康,(+)-Irinotecan |
Topoisomerase; Autophagy | Autophagy; DNA Damage/DNA Repair |
Irinotecan (CPT-11) 是喜树碱的衍生物,是一种 DNA 拓扑异构酶 I (Topo I) 的抑制剂。Irinotecan 通过与 Topo I 复合物结合来阻止 DNA 链的重新连接,并导致双链 DNA 断裂和细胞死亡,具有抗肿瘤活性。 | |||
T0486L |
Irinotecan Hydrochloride
盐酸伊立替康,伊立替康盐酸盐,Camptothecin 11 hydrochloride,CPT-11 hydrochloride |
Topoisomerase; Autophagy | Autophagy; DNA Damage/DNA Repair |
Irinotecan Hydrochloride (CPT-11 hydrochloride) 是喜树碱半合成衍生物的盐酸盐,是一种拓扑异构酶 I 抑制剂,可研究结肠癌和直肠癌。 | |||
T0486 |
Irinotecan hydrochloride trihydrate
Irinotecan HCl Trihydrate,CPT-11 HCl Trihydrate,盐酸伊立替康三水合物 |
Topoisomerase; Autophagy | Autophagy; DNA Damage/DNA Repair |
Irinotecan hydrochloride trihydrate (CPT-11 HCl Trihydrate) 通过抑制拓扑异构酶 1 来防止 DNA 展开,可研究结肠癌和直肠癌。 |